| Title : Rivastigmine and donepezil treatment in moderate to moderately-severe Alzheimer's disease over a 2-year period - Bullock_2005_Curr.Med.Res.Opin_21_1317 |
| Author(s) : Bullock R , Touchon J , Bergman H , Gambina G , He Y , Rapatz G , Nagel J , Lane R |
| Ref : Curr Med Res Opin , 21 :1317 , 2005 |
| Abstract : Bullock_2005_Curr.Med.Res.Opin_21_1317 |
| ESTHER : Bullock_2005_Curr.Med.Res.Opin_21_1317 |
| PubMedSearch : Bullock_2005_Curr.Med.Res.Opin_21_1317 |
| PubMedID: 16083542 |
Bullock R, Touchon J, Bergman H, Gambina G, He Y, Rapatz G, Nagel J, Lane R (2005)
Rivastigmine and donepezil treatment in moderate to moderately-severe Alzheimer's disease over a 2-year period
Curr Med Res Opin
21 :1317
Bullock R, Touchon J, Bergman H, Gambina G, He Y, Rapatz G, Nagel J, Lane R (2005)
Curr Med Res Opin
21 :1317